'The cavalry is on the way': Fauci says Americans should 'double down' on COVID-19 precautions as we reach the final stretch before the first vaccines
- This month, Moderna, BioNTech, and Pfizer all announced that their
COVID-19vaccine candidates had passed phase 3 testing.
- Dr. Anthony
Fauci, the nation's leading expert on COVID-19, said that Americans should take the breakthroughs as more reason to combat "COVID fatigue," at The New York Times DealBook conference Tuesday.
- "The cavalry is on the way," Fauci said.
Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, warned that Americans should "double down" on public
"We've been fortunate enough that the
While these vaccine trials have given many reason for hope, case numbers and deaths from this week have been more sobering: 166,272 cases per day and an average of about 1,200 deaths per day, according to The New York Times.Read more: Pharmacies, doctor's offices and hospitals are gearing up to give coronavirus vaccines to millions of Americans. Here's how they're preparing and how much they stand to profit along the way.
Fauci warned on Tuesday that across the globe, people were feeling "covid fatigue," that is, that they were becoming tired of social distancing and other public health measures after months of quarantine."I get on the phone with my colleagues in Italy, in the UK," Fauci said, "They're telling us the same thing." However, Americans should strengthen their efforts to socially distance, especially given promising
"The cavalry is on the way," Fauci said. "Rather than give up on public health measures, we should say: 'Now that we see the end in sight, now is the time to double down.'"
Fauci highlighted that as the holidays near, families need to make a risk assessment. Fauci said he and his wife would be holding a small
The Food and Drug Administration has not approved Moderna's or Pfizer/BioNTech's vaccine candidates yet. In addition, the findings of the vaccine trials have not been peer reviewed. But in an important next step, Pfizer and BioNTech announced that they were requesting emergency approval from the FDA on Friday. Moderna has yet to file, but will likely do so in the next few days.
- PM's visit to vaccine centres gets 'praise' from Congress
- Pollution, pandemic and pre-term birth
- Serum Institute of India threatens to seek ₹100 crore in damages from Chennai volunteer
- PM to interact with more teams of Covid-19 vaccine developers
- UP to have cold chain space for 1.23L litres of vaccine